Overview
If you are researching peptides that affect growth hormone pathways, tissue repair, or metabolic function, blood work is the single most important tool for understanding what is actually happening biologically. This guide explains which blood markers matter, why they matter, what reference ranges mean, and how to interpret changes in the context of peptide research.
Important: This guide is for educational and research purposes only. It is not medical advice. Blood test results should always be interpreted by a qualified healthcare professional who knows your full medical history.
Why Blood Work Matters in Peptide Research
Peptides can influence hormone levels, inflammatory markers, metabolic pathways, and tissue turnover. Without blood work, researchers are working blind — relying on subjective feelings rather than objective data. Blood work allows researchers to:
- Establish a baseline before any peptide research begins
- Monitor for unexpected changes — both positive and negative
- Detect safety signals early — such as elevated liver enzymes or altered glucose metabolism
- Track research outcomes objectively rather than relying on subjective reports
When to Test
A structured testing schedule for research purposes typically looks like this:
- Baseline (pre-research) — 1–2 weeks before beginning any peptide protocol. This establishes your individual reference point.
- Mid-cycle — Approximately halfway through a research cycle. This helps detect any acute changes.
- Post-cycle — 2–4 weeks after completing a cycle. This shows whether values return to baseline or remain altered.
- Long-term follow-up — 8–12 weeks post-cycle, to check for delayed effects or recovery.
Fasting Requirements
Most hormone and metabolic panels require fasting for 8–12 hours beforehand. Water is generally fine; avoid caffeine, alcohol, and vigorous exercise for 24 hours before the draw. For hormone panels, timing matters — testosterone and growth hormone pulses mean that morning draws (ideally between 7–10am) give the most consistent results.
Key Blood Markers by Peptide Category
Growth Hormone Secretagogues (CJC-1295, Ipamorelin, and similar)
These peptides stimulate growth hormone (GH) release and, consequently, insulin-like growth factor 1 (IGF-1) production. The relevant markers are:
| Marker | Why It Matters | What to Watch For |
|---|---|---|
| Serum IGF-1 | The primary downstream marker of GH activity. IGF-1 has a longer half-life than GH and is more stable to measure. | Elevations above age-adjusted reference range may indicate excessive GH signalling. Persistently high IGF-1 has been associated with acromegalic changes in clinical literature (Clemmons DR, "IGF-I assays: current assay methodologies," Growth Hormone & IGF Research, 2007, doi:10.1016/j.ghir.2007.05.008). |
| Growth Hormone (serum) | Direct measure of GH in blood. However, GH is pulsatile, making single measurements unreliable. | A single low or high reading is not necessarily meaningful due to pulsatile secretion. IGF-1 is a better integrated marker. |
| Fasting insulin | GH antagonises insulin action. Elevated GH can reduce insulin sensitivity. | Rising fasting insulin may indicate developing insulin resistance. |
| Fasting glucose / HbA1c | Monitors glucose metabolism, which can be affected by GH pathway activation. | Elevated fasting glucose or HbA1c trending upward may signal impaired glucose tolerance. |
| Lipid panel | GH can affect lipid metabolism. | Changes in LDL, HDL, or triglycerides may be observed. |
Tissue Repair Peptides (BPC-157, TB-500)
| Marker | Why It Matters | What to Watch For |
|---|---|---|
| CRP (C-Reactive Protein) | General marker of systemic inflammation. BPC-157 has been studied for anti-inflammatory effects, primarily in animal models. | Baseline CRP gives context; changes during research may reflect inflammatory status. Note: most evidence is preclinical (Sikiric P et al., "Brain-gut axis and pentadecapeptide BPC 157," Journal of Physiology and Pharmacology, 2014, PMID: 2527235). |
| ESR (Erythrocyte Sedimentation Rate) | Another non-specific inflammation marker. | Trend alongside CRP for a fuller inflammatory picture. |
| CBC (Complete Blood Count) | Monitors white blood cells (infection/inflammation), red blood cells, and platelets. | Abnormalities in WBC differentials may indicate immune system effects. |
| Liver function (ALT, AST, ALP, bilirubin) | General health monitoring; some peptides are metabolised hepatically. | Elevated liver enzymes may indicate hepatic stress. |
| Kidney function (creatinine, eGFR, urea) | Baseline organ function monitoring. | Significant changes should prompt immediate cessation and medical review. |
Metabolic Peptides (MOTS-c)
| Marker | Why It Matters | What to Watch For |
|---|---|---|
| Fasting glucose / HbA1c | MOTS-c has been studied for its effects on metabolic homeostasis and glucose regulation, primarily in animal and in vitro models. | Changes in glucose or HbA1c may indicate metabolic effects. Evidence is largely preclinical (Lee C et al., "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance," Cell Metabolism, 2015, doi:10.1016/j.cmet.2015.06.023). |
| Fasting insulin / HOMA-IR | Insulin resistance index. | A decrease in HOMA-IR may suggest improved insulin sensitivity, though human trial data is lacking. |
| Lipid panel | MOTS-c research suggests possible effects on lipid metabolism. | Monitor for shifts in triglycerides and cholesterol fractions. |
| Lactate | MOTS-c interacts with the folate-purine-AMPK pathway; lactate may reflect metabolic shifts. | Elevated lactate warrants medical attention. |
Understanding Reference Ranges
Blood test results are reported with a reference range — the range of values considered "normal" for a healthy population. Understanding how these work is essential:
- Reference ranges are population-based — They are derived from a statistical sample (often the middle 95% of a reference population). Being just outside the range does not necessarily mean something is wrong.
- Ranges vary by lab — Different laboratories use different assay methods and may have slightly different reference ranges. Always compare results to the specific lab's stated range. | Your personal baseline is more informative than the population range — A value within the "normal" range that represents a significant change from your own baseline may be more meaningful than a value slightly outside the range that is stable over time.
- Age and sex matter — IGF-1, testosterone, and other hormones decline with age. Reference ranges are often age-adjusted, but not always. Ensure you are comparing against the appropriate range.
A Note on "Optimal" vs "Normal"
Some researchers distinguish between "normal" (statistically average) and "optimal" (associated with best health outcomes). For example, the "normal" range for fasting insulin may extend quite high, while functional medicine practitioners often suggest that optimal fasting insulin is lower. This guide does not take a position on optimal ranges — researchers should discuss this with a healthcare professional.
How to Get Blood Work Done in the UK
NHS Route
If you have a medical condition that warrants blood testing (e.g., suspected hormone deficiency, metabolic disorder), your GP can order blood tests on the NHS. However, GPs are unlikely to order tests specifically for monitoring peptide research, as this falls outside standard clinical care.
Private Blood Testing
Several UK providers offer private blood tests that you can order directly, including:
- Nuffield Health — full health assessments including blood panels
- Medichecks — wide range of blood tests available by post or at collection points
- Thriva — at-home finger-prick blood tests with GP-reviewed results
- Randox Health — comprehensive preventive health screening
These services typically provide results with reference ranges and sometimes a GP interpretation. Costs vary widely depending on the panel.
What to Ask For
If booking a private test, ask for a panel that includes:
- Full blood count (CBC)
- Comprehensive metabolic panel (liver function, kidney function, fasting glucose)
- Lipid panel (total cholesterol, LDL, HDL, triglycerides)
- HbA1c
- Fasting insulin
- IGF-1 (if researching GH secretagogues)
- CRP and ESR (if researching healing/inflammation peptides)
- Thyroid panel (TSH, free T3, free T4) — useful as a general endocrine baseline
- Testosterone (total and free) and SHBG — for male researchers, as GH pathways can interact with the HPG axis
Red Flags: When to Stop and Seek Medical Attention
Certain blood test results warrant immediate cessation of any peptide research and consultation with a healthcare professional:
- ALT or AST >3x the upper limit of normal — Potential hepatotoxicity
- Creatinine significantly elevated from baseline or eGFR <60 — Potential kidney stress
- Fasting glucose >7.0 mmol/L or HbA1c >48 mmol/mol — Potential diabetes-range values
- Haemoglobin or haematocrit significantly below baseline — Potential anaemia
- White blood cell count significantly elevated or suppressed — Potential immune system disruption
- Any value your interpreting GP flags as concerning
These thresholds are informational, not diagnostic. A healthcare professional should interpret your results in the context of your full health picture.
Data Tracking for Research Purposes
For researchers who want to track data systematically:
- Use a spreadsheet — Record each marker, the value, the lab's reference range, the date, and whether you were fasting.
- Track trends, not single values — A single data point is less informative than a trend over time.
- Note your research protocol alongside — Record what peptide, what dose, what day of the cycle, and any other variables. This context is essential for interpreting changes.
- Share with your healthcare provider — If you are working with a doctor, sharing your tracking data can help them give you better-informed advice.
Key Takeaways
- Always get baseline blood work before starting any peptide research.
- Different peptide categories require different marker focus — GH secretagogues need IGF-1 and glucose/insulin; healing peptides need inflammatory markers; metabolic peptides need metabolic panels.
- Your personal baseline is more informative than population reference ranges.
- Test at baseline, mid-cycle, post-cycle, and long-term follow-up.
- Know the red flags — certain results warrant immediate cessation and medical review.
- Private blood testing is readily available in the UK — you do not need to rely solely on the NHS.
Disclaimer
This guide is for educational and research purposes only. It does not constitute medical advice. Blood test results should always be interpreted by a qualified healthcare professional. Peptide Data does not endorse or encourage the use of research peptides for human consumption.
References
- Clemmons DR, "IGF-I assays: current assay methodologies and their limitations," Growth Hormone & IGF Research, 2007. doi:10.1016/j.ghir.2007.05.008
- Sikiric P et al., "Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications," Journal of Physiology and Pharmacology, 2014. PMID: 2527235
- Lee C et al., "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance," Cell Metabolism, 2015. doi:10.1016/j.cmet.2015.06.023
- Yuen KCJ, Biller BMK, "Search for the magic pill: the growth hormone secretagogues," Endocrine Practice, 2018. doi:10.4158/EP-2017-00931
- NICE, "Type 2 diabetes in adults: management," NICE guideline NG28, 2015 (updated 2022). Available at: https://www.nice.org.uk/guidance/ng28
- NHS, "Blood tests," nhs.uk. Available at: https://www.nhs.uk/conditions/blood-tests/